Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets
Open accessThe DOI matches its Crossref record; 246 of the 246 references it cites were found in a registry or an index.
Abstract
Atherosclerosis, a chronic inflammatory disorder of the arteries, is responsible for most deaths in westernized societies with numbers increasing at a marked rate in developing countries. The disease is initiated by the activation of the endothelium by various risk factors leading to chemokine-mediated recruitment of immune cells. The uptake of modified lipoproteins by macrophages along with defective cholesterol efflux gives rise to foam cells associated with the fatty streak in the early phase of the disease. As the disease progresses, complex fibrotic plaques are produced as a result of lysis of foam cells, migration and proliferation of vascular smooth muscle cells and continued inflammatory response. Such plaques are stabilized by the extracellular matrix produced by smooth muscle cells and destabilized by matrix metalloproteinase from macrophages. Rupture of unstable plaques and subsequent thrombosis leads to clinical complications such as myocardial infarction. Cytokines are involved in all stages of atherosclerosis and have a profound influence on the pathogenesis of this disease. This review will describe our current understanding of the roles of different cytokines in atherosclerosis together with therapeutic approaches aimed at manipulating their actions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–246 of 246
Namiki, M., Kawashima, S., Yamashita, T., Ozaki, M., Sakoda, T., Inoue, N., Hirata, K., Morishita, R., Kaneda, Y., & Yokoyama, M. (2003) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2003.08.032 · Cited by 60
IL-6 and the acute phase response in murine atherosclerosis
Song, L., & Schindler, C. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.06.018 · Cited by 59
Upadhya, S., Mooteri, S., Peckham, N., & Pai, R. G. (2004) · Angiology · doi:10.1177/000331970405500308 · Cited by 59
Genetic Deletion of Chemokine Receptor Ccr6 Decreases Atherogenesis inApoE-Deficient Mice
Wan, W., Lim, J. K., Lionakis, M. S., Rivollier, A., McDermott, D. H., Kelsall, B. L., Farber, J. M., & Murphy, P. M. (2011) · Circulation Research · doi:10.1161/circresaha.111.242578 · Cited by 58
Attenuation of Experimental Atherosclerosis by Interleukin-19
Ellison, S., Gabunia, K., Kelemen, S. E., England, R. N., Scalia, R., Richards, J. M., Orr, A. W., Traylor, J. G., Rogers, T., Cornwell, W., et al. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.301521 · Cited by 58
Pejnovic, N. N., Vratimos, A., Lee, S. E., Popadic, D. M., Takeda, K., Akira, S., & Chan, W. L. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2008.12.032 · Cited by 55
IL-25 Inhibits Atherosclerosis Development in Apolipoprotein E Deficient Mice
Mantani, P. T., Dunér, P., Bengtsson, E., Alm, R., Ljungcrantz, I., Söderberg, I., Sundius, L., To, F., Nilsson, J. Å., Björkbacka, H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117255 · Cited by 55
Zhang, K., Huang, X., Li, X., Feng, M., Li, L., Cai, X., Zhang, C., Liu, X., Zhang, M., Zhang, Y., et al. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.09.007 · Cited by 54
Monocyte Chemoattractant Protein-1 Deficiency Protects Against Visceral Fat-Induced Atherosclerosis
Öhman, M. K., Wright, A. P., Wickenheiser, K. J., Luo, W., Russo, H. M., & Eitzman, D. T. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.205914 · Cited by 51
Pascual-García, M., Rué, L., León, T., Julve, J., Carbó, J. M., Matalonga, J., Auer, H., Celada, A., Escolà-Gil, J. C., Steffensen, K. R., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201393 · Cited by 51
Guo, J., de Waard, V., Eck, M. V., Hildebrand, R. B., van Wanrooij, E. J. A., Kuiper, J., Maeda, N., Benson, G. M., Groot, P. H. E., & van Berkel, T. J. C. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000163181.40896.42 · Cited by 49
Michael, D. R., Ashlin, T. G., Davies, C. S., Gallagher, H., Stoneman, T. W., Buckley, M. L., & Ramji, D. P. (2013) · Cytokine · doi:10.1016/j.cyto.2013.05.016 · Cited by 49
Self-citationNiwa, T., Wada, H., Ohashi, H., Iwamoto, N., Ohta, H., Kirii, H., Fujii, H., Saito, K., & Seishima, M. (2004) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.11.79 · Cited by 49
Reifenberg, K., Cheng, F., Orning, C., Crain, J., Küpper, I., Wiese, E., Protschka, M., Blessing, M., Lackner, K. J., & Torzewski, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040990 · Cited by 49
Shemesh, S. S., Kamari, Y., Shaish, A., Olteanu, S., Kandel-Kfir, M., Almog, T., Grosskopf, I., Apte, R. N., & Harats, D. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.12.010 · Cited by 48
Interleukin‐1 Mediates Neuroinflammatory Changes Associated With Diet‐Induced Atherosclerosis
Dénes, Á., Drake, C., Stordy, J., Chamberlain, J., McColl, B. W., Gram, H., Crossman, D. C., Francis, S., Allan, S. M., & Rothwell, N. J. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.002006 · Cited by 48
IL-15 aggravates atherosclerotic lesion development in LDL receptor deficient mice
van Es, T., van Puijvelde, G. H. M., Michon, I. N., van Wanrooij, E. J. A., de Vos, P., Peterse, N., van Berkel, T. J. C., & Kuiper, J. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.11.037 · Cited by 47
Interleukin-10 attenuates the response to vascular injury1,2
Zimmerman, M. A., Reznikov, L. L., Raeburn, C. D., & Selzman, C. H. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.03.025 · Cited by 46
Olzinski, A. R., Turner, G. H., Bernard, R. E., Karr, H. W., Cornejo, C., Aravindhan, K., Hoang, B. Q., Ringenberg, M. A., Qin, P., Goodman, K. B., et al. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.198812 · Cited by 46
Genetic deletion of chemokine receptor Ccr7 exacerbates atherogenesis in ApoE-deficient mice
Wan, W., Lionakis, M. S., Liu, Q., Roffê, E., & Murphy, P. M. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs349 · Cited by 45
Sastre, C., Fernández‐Laso, V., Madrigal‐Matute, J., Muñoz‐García, B., Moreno, J. A., Pastor‐Vargas, C., Llamas‐Granda, P., Burkly, L. C., Egido, J., Martín-Ventura, J. L., et al. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12221 · Cited by 44
Michael, D. R., Salter, R. C., & Ramji, D. P. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.06.002 · Cited by 43
Self-citationAli, Z. A., Bursill, C. A., Hu, Y., Choudhury, R. P., Xu, Q., Greaves, D. R., & Channon, K. M. (2005) · Circulation · doi:10.1161/circulationaha.104.526129 · Cited by 40
CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions
Akhavanpoor, M., Gleissner, C. A., Gorbatsch, S., Doesch, A. O., Akhavanpoor, H., Wangler, S., Jahn, F., Lasitschka, F., Katus, H. A., & Erbel, C. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s72394 · Cited by 40
Liver X Receptors, Atherosclerosis and Inflammation
Michael, D. R., Ashlin, T. G., Buckley, M. L., & Ramji, D. P. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0239-y · Cited by 39
Self-citationMunoz-Garcia, B., Madrigal‐Matute, J., Moreno, J. A., Martı́n-Ventura, J. L., López‐Franco, Ó., Sastre, C., Ortega, L. M., Burkly, L. C., Egido, J., & Blanco‐Colio, L. M. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq278 · Cited by 37
Zhang, L.-N., Velichko, S., Vincelette, J., Fitch, R. M., Vergona, R. A., Sullivan, M. E., Croze, E., & Wang, Y. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.03.019 · Cited by 37
Huang, C., Zhang, Y., Wang, J., Jiang, J., & Bao, J. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m032482 · Cited by 36
A VLP‐based vaccine against interleukin‐1α protects mice from atherosclerosis
Tissot, A. C., Spohn, G., Jennings, G. T., Shamshiev, A. T., Kurrer, M. O., Windak, R., Meier, M., Viesti, M., Hersberger, M., Kündig, T. M., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201242687 · Cited by 36
Xanthoulea, S., Gijbels, M. J., van der Made, I., Mujčić, H., Thelen, M., Vergouwe, M. N., Ambagts, M. H. C., Hofker, M. H., & de Winther, M. P. J. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn193 · Cited by 35
Kennedy, A. J., Gruen, M. L., Gutierrez, D. A., Surmi, B. K., Orr, J. S., Webb, C. D., & Hasty, A. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031508 · Cited by 34
Lentiviral gene transfer to reduce atherosclerosis progression by long-term CC-chemokine inhibition
Bursill, C. A., McNeill, E., Wang, L., Hibbitt, O., Wade‐Martins, R., Paterson, D. J., Greaves, D. R., & Channon, K. M. (2008) · Gene Therapy · doi:10.1038/gt.2008.141 · Cited by 34
Li, N., Salter, R. C., & Ramji, D. P. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22976 · Cited by 33
Self-citationEllison, S. P., Gabunia, K., Richards, J. M., Kelemen, S. E., England, R. N., Rudic, R. D., Azuma, Y., Monroy, A. M., Eguchi, S., & Autieri, M. V. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.04.001 · Cited by 32
Koga, M., Kai, H., Yasukawa, H., Kato, S., Yamamoto, T., KAWAI, Y., KUSABA, K., Seki, Y., Kai, M., Egashira, K., et al. (2007) · Hypertension Research · doi:10.1291/hypres.30.259 · Cited by 30
CCR6 selectively promotes monocyte mediated inflammation and atherogenesis in mice
Manthey, H. D., Cochain, C., Barnsteiner, S., Karshovska, E., Pelisek, J., Koch, M., Chaudhari, S. M., Busch, M., Eckstein, H., Weber, C., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-01-0017 · Cited by 28
Hamesch, K., Subramanian, P., Li, X., Dembowsky, K., Chevalier, É., Weber, C., & Schober, A. (2012) · Thrombosis and Haemostasis · doi:10.1160/th11-07-0453 · Cited by 24
Overexpression of CXCL16 promotes a vulnerable plaque phenotype in Apolipoprotein E–Knockout Mice
Yi, G., Zeng, Q., Mao, X., Cheng, M., Yang, X., Liu, H., Mao, Y., Guo, M., Ji, Q., & Zhong, Y. (2010) · Cytokine · doi:10.1016/j.cyto.2010.11.016 · Cited by 23
Tang, T., Wilson, P. G., Thompson, J. C., Nelson, C., Yoder, M. H., & Tannock, L. R. (2013) · Journal of Lipid Research · doi:10.1194/jlr.p040139 · Cited by 21
Autocrine role of vascular IL-15 in intimal thickening
Čerček, M., Matsumoto, M., Li, H., Chyu, K., Peter, A. J. L., Shah, P. K., & Dimayuga, P. C. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.050 · Cited by 20
Isoda, K., Akita, K., Isobe, S., Niida, T., Adachi, T. K., Iwakura, Y., & Daida, H. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.25668 · Cited by 17
Interleukin-17A Exacerbates Ferric Chloride-Induced Arterial Thrombosis in Rat Carotid Artery
Μaione, F., Parisi, A., Caiazzo, E., Morello, S., D’Acquisto, F., Mascolo, N., & Cicala, C. (2014) · International Journal of Inflammation · doi:10.1155/2014/247503 · Cited by 17
Gourdy, P., Schambourg, A., Filipe, C., Douin‐Echinard, V., Garmy-Susini, B. H., Calippe, B., Tercé, F., Bayard, F., & Arnal, J. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.150300 · Cited by 15
Sinha, S. K., Mishra, V., Nagwani, S., & Rajavashisth, T. B. (2014) · Europe PMC (PubMed Central) · Cited by 11
Role of regulatory T cells in atheroprotective effects of granulocyte colony-stimulating factor
Uchiyama, R., Hasegawa, H., Kameda, Y., Ueda, K., Kobayashi, Y., Komuro, I., & Takano, H. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.12.016 · Cited by 11
Cochain, C., & Zernecke, A. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000108 · Cited by 7
Cited by
Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines
Rea, I. M., Gibson, D. S., McGilligan, V., McNerlan, S. E., Alexander, H. D., & Ross, O. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00586 · Cited by 1,267
“Cytokines are involved in all stages of the pathogenesis of atherosclerosis, having both pro- or anti-atherogenic effects (342, 343).”
BackgroundMCP-1: Function, regulation, and involvement in disease
Singh, S., Anshita, D., & Ravichandiran, V. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107598 · Cited by 883
Inflammatory cytokines in atherosclerosis: current therapeutic approaches
Tousoulis, D., Oikonomou, E., Economou, E. K., Crea, F., & Kaski, J. C. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv759 · Cited by 460
ICAM-1 and VCAM-1: Gatekeepers in various inflammatory and cardiovascular disorders
Singh, V., Kaur, R., Kumari, P., Pasricha, C., & Singh, R. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117487 · Cited by 432
Zhu, X., Chen, Z., Shen, W., Huang, G., Sedivy, J. M., Wang, H., & Ju, Z. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00646-9 · Cited by 393
Metadata
- Authors
- Ramji, D. P., & Davies, T. S.
- Venue
- Cytokine & Growth Factor Reviews
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 26
- Issue
- 6
- Pages
- 673-685
- ISSN
- 1359-6101 (ISSN-L)
- OpenAlex
- W1840986526
- Cited by
- 469
- References
- 246
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.